Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Agios Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 153
- −11 vs. Q1 2023
- Shares held
- 59.4M
- +535.9K (+0.9%) vs. Q1 2023
- Total value
- $1.68B
- +$325.2M (+24.0%) vs. Q1 2023
- New holders
- 11
- 63 more added
- Sold out
- 22
- 50 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 238 | $2.45B |
| Q1 2026 | 234 | $2.12B |
| Q4 2025 | 238 | $1.67B |
| Q3 2025 | 221 | $2.55B |
| Q2 2025 | 216 | $2.05B |
| Q1 2025 | 221 | $1.76B |
| Q4 2024 | 225 | $1.97B |
| Q3 2024 | 208 | $2.58B |
| Q2 2024 | 206 | $2.51B |
| Q1 2024 | 187 | $1.81B |
| Q4 2023 | 170 | $1.33B |
| Q3 2023 | 146 | $1.46B |
| Q2 2023 | 153 | $1.68B |
| Q1 2023 | 165 | $1.36B |
| Q4 2022 | 160 | $1.67B |
| Q3 2022 | 168 | $1.64B |
| Q2 2022 | 157 | $1.31B |
| Q1 2022 | 161 | $1.74B |
| Q4 2021 | 161 | $1.95B |
| Q3 2021 | 165 | $2.81B |
| Q2 2021 | 186 | $3.63B |
| Q1 2021 | 175 | $3.37B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Agios Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 80,083 | $2.27M | 0.01% | −42,451−34.6% | Reduced |
| State of New Jersey Common Pension Fund D | 94,772 | $2.68M | 0.01% | +7,234+8.3% | Added |
| D. E. Shaw & Co., Inc. | 95,860 | $2.71M | 0.00% | −6,286−6.2% | Reduced |
| Rhumbline Advisers | 100,882 | $2.86M | 0.00% | +9,477+10.4% | Added |
| Allianz Asset Management GmbH | 111,173 | $3.15M | 0.01% | +2,150+2.0% | Added |
| Prudential Financial Inc | 112,852 | $3.20M | 0.00% | +112,852 | New |
| Swiss National Bank | 120,360 | $3.41M | 0.00% | +13,700+12.8% | Added |
| ExodusPoint Capital Management, LP | 120,363 | $3.41M | 0.04% | −78,003−39.3% | Reduced |
| Credit Suisse AG | 120,765 | $3.42M | 0.00% | +18,334+17.9% | Added |
| Wells Fargo & Company | 142,171 | $4.03M | 0.00% | −7,947−5.3% | Reduced |
| Jacobs Levy Equity Management, Inc | 144,611 | $4.10M | 0.02% | −469,922−76.5% | Reduced |
| Nuveen Asset Management, LLC | 156,036 | $4.42M | 0.00% | −205,156−56.8% | Reduced |
| Barclays PLC | 158,725 | $4.50M | 0.00% | +62,896+65.6% | Added |
| Rafferty Asset Management, LLC | 163,607 | $4.63M | 0.03% | −42,538−20.6% | Reduced |
| Man Group plc | 170,631 | $4.83M | 0.01% | – | – |
| Millennium Management LLC | 174,005 | $4.93M | 0.01% | +112,316+182.1% | Added |
| Citadel Advisors LLC | 175,191 | $4.96M | 0.01% | −107,963−38.1% | Reduced |
| Norges Bank | 203,129 | $5.75M | 0.00% | −77,640−27.7% | Reduced |
| UBS Asset Management Americas Inc | 250,534 | $5.75M | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 209,946 | $5.95M | 0.00% | +3,232+1.6% | Added |
| Balyasny Asset Management LLC | 218,100 | $6.18M | 0.02% | −102,907−32.1% | Reduced |
| Nordea Investment Management AB | 247,343 | $6.97M | 0.01% | −59,100−19.3% | Reduced |
| Bank of America Corp | 253,006 | $7.17M | 0.00% | −170,426−40.2% | Reduced |
| Hudson Bay Capital Management LP | 260,000 | $7.36M | 0.07% | −10,000−3.7% | Reduced |
| Eagle Health Investments LP | 267,630 | $7.58M | 1.42% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 325,221 | $9.21M | 0.00% | +19,507+6.4% | Added |
| AXA S.A. | 357,066 | $10.1M | 0.03% | +1,955+0.6% | Added |
| Morgan Stanley | 391,467 | $11.1M | 0.00% | +80,685+26.0% | Added |
| Charles Schwab Investment Management Inc | 437,275 | $12.4M | 0.00% | +7,463+1.7% | Added |
| Suvretta Capital Management, LLC | 454,000 | $12.9M | 0.69% | 00.0% | Unchanged |
| Deutsche Bank AG | 577,975 | $16.4M | 0.01% | −11,996−2.0% | Reduced |
| Northern Trust Corp | 709,708 | $20.1M | 0.00% | +35,399+5.2% | Added |
| Goldman Sachs Group Inc | 799,612 | $22.6M | 0.01% | −164,550−17.1% | Reduced |
| Fisher Asset Management, LLC | 871,099 | $24.7M | 0.01% | +20,667+2.4% | Added |
| Pictet Asset Management SA | 882,402 | $25.0M | 0.03% | +186,326+26.8% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 928,259 | $26.3M | 0.08% | −98,328−9.6% | Reduced |
| T. Rowe Price Investment Management, Inc. | 930,051 | $26.3M | 0.02% | −37,200−3.8% | Reduced |
| Geode Capital Management, LLC | 1,157,667 | $32.8M | 0.00% | +68,308+6.3% | Added |
| Price T Rowe Associates Inc | 1,293,392 | $36.6M | 0.01% | +29,695+2.3% | Added |
| ArrowMark Colorado Holdings LLC | 1,573,254 | $44.6M | 0.49% | +15,549+1.0% | Added |
| Macquarie Group Ltd | 1,626,960 | $46.1M | 0.05% | +179,572+12.4% | Added |
| Erste Asset Management GmbH | 1,694,200 | $47.9M | 0.85% | 00.0% | Unchanged |
| First Trust Advisors LP | 2,160,576 | $61.2M | 0.07% | +322,959+17.6% | Added |
| Dimensional Fund Advisors LP | 2,263,818 | $64.1M | 0.02% | +172,467+8.2% | Added |
| JPMorgan Chase & Co | 2,492,975 | $70.6M | 0.01% | +1,294,462+108.0% | Added |
| State Street Corp | 2,581,469 | $73.1M | 0.00% | −482,533−15.7% | Reduced |
| Rock Springs Capital Management LP | 2,686,167 | $76.1M | 1.81% | +24,562+0.9% | Added |
| Farallon Capital Management, L.L.C. | 2,688,829 | $76.1M | 0.46% | +596,000+28.5% | Added |
| Armistice Capital, LLC | 3,256,000 | $92.2M | 2.31% | −204,000−5.9% | Reduced |
| Bellevue Group AG | 4,013,500 | $113.7M | 1.62% | 00.0% | Unchanged |
| BlackRock Inc. | 4,726,274 | $133.8M | 0.00% | −90,801−1.9% | Reduced |
| Vanguard Group Inc | 5,519,587 | $156.3M | 0.00% | +95,660+1.8% | Added |
| Wellington Management Group LLP | 5,865,628 | $166.1M | 0.03% | +142,497+2.5% | Added |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −213,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −134,396−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −52,670−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −24,659−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −24,613−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −23,865−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −22,525−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −20,052−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −20,160−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −14,755−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,956−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,802−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −9,817−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,789−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,086−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −186−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Schubert & Co | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |